Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simplified Geriatric Assessment-Based Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer: Protocol for a Prospective Multicenter Cohort Study (SGA-OCRC)

NCT07903129 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT07903129 Not yet recruiting Observational 1,000 participants (estimated) Started 2027

Follow this trial by email Email me the PDF

Get the NCT07903129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started June 2027. Observational study, 1,000 participants (estimated). Lead sponsor Second Affiliated Hospital, Zhejiang University, School of Medicine. Primary measure: 90-day major adverse postoperative outcomes (MAPO).

How it compares

1,394 similar trials: same condition (Colorectal Neoplasms) and phase

Enrollment

This trial
1,000
Middle half
80 to 850
Median
250
Trials with a value
1,384

Months from start to completion

This trial
39
Middle half
20 to 66
Median
36.5
Trials with a value
1,362

Sites

This trial
Not reported
Middle half
1 to 2
Median
1
Trials with a value
1,238
Posted results or a linked paper 35% 487 of 1,394 similar trials; this trial: no

Registry record

As filed in ClinicalTrials.gov.

Title
Simplified Geriatric Assessment-Based Prediction of 90-Day Major Adverse Postoperative Outcomes in Octogenarian Patients With Non-metastatic Resectable Colorectal Cancer: Protocol for a Prospective Multicenter Cohort Study (SGA-OCRC)
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2027
Completion date
September 30, 2030
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

MeSH condition names; the registry's own terms follow.

Colorectal Neoplasms, Postoperative Complications

Registry terms: octogenarian patients with non-metastatic resectable colorectal cancer

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
All
Minimum age
80 Years
Healthy volunteers
No
Study type
Observational
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine

Arms

As registered; 2 arms.

Registered arms
Arm Type Interventions
Surgical Cohort
Show registry wording

Patients who undergo curative-intent colorectal resection will form the primary analysis cohort

Non-surgical Cohort
Show registry wording

Patients who fail to receive surgical resection will form the primary analysis cohort

Primary endpoints

Registered primary outcome measures; 1 primary.

Registered primary endpoints
Measure Time frame
90-day major adverse postoperative outcomes (MAPO) 90 days after surgery
Show registry wording

The primary outcome is 90-day major adverse postoperative outcomes (MAPO), defined as the occurrence of any of the following:

1. Clavien-Dindo grade ≥III complication: a postoperative complication requiring surgical, endoscopic, or radiological intervention, or more intensive treatment for life-threatening complications.
2. Unplanned ICU admission: an unexpected transfer to the intensive care unit for postoperative monitoring or organ support.
3. Mechanical ventilation \>48 h: the need for invasive mechanical ventilation for more than 48 hours after surgery.
4. 30- or 90-day all-cause mortality: death from any cause within 30 or 90 days after surgery.
5. Unplanned readmission within 90 days: an unexpected hospital admission within 90 days after discharge from the index hospitalization.

The primary composite outcome will be analyzed as a binary variable. Patients will be classified as having MAPO if at least one qualifying event occurs within 90 days after surgery.

Lead sponsor's other trials

Second Affiliated Hospital, Zhejiang University, School of Medicine, most recent start first.

Similar trials

Same condition (Colorectal Neoplasms) and phase, most recent start first.